| Abstrakt: |
Immobilized collagenase (collapor) applied as ophthalmic medicinal films has been developed and clinically tried. A new long-acting base (aubasidan, a mucopolysaccharide of a bacterial origin), similar as the main medicinal component, collagenase, exerts a therapeutic effect. Collapor is characterized by a pronounced resolving and proteolytic action causing no appreciable side effects. Altogether 134 patients with various inflammatory and vascular diseases of the eyes were observed. An instruction for collapor application in ophthalmology is offered. |
